本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Ascendis Pharma A/S

174.71
-0.0400-0.02%
成交量:27.20万
成交额:4,719.30万
市值:105.79亿
市盈率:-27.76
高:176.19
开:175.00
低:171.10
收:174.75
数据加载中...
2019/10/08

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/09/26

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/09/13

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/08/28

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/08/14

超过5%披露

[Amend] General statement of acquisition of beneficial ownership
2019/08/14

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/07/18

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/07/10

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/07/01

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/06/26

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/06/18

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/06/14

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/06/10

超过5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2019/05/30

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/05/30

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/05/16

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/05/01

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/04/19

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/04/12

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/04/03

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]